Publisher: Icon Group International, Inc.
Category: Biopharmaceuticals

Biopharmaceuticals market research reports by Icon Group International, Inc.

(105 reports matching your criteria)
    • The 2025-2030 World Outlook for Upstream Biopharmaceutical Fermentation Products

      The 2025-2030 World Outlook for Upstream Biopharmaceutical Fermentation Products This study covers the world outlook for upstream biopharmaceutical fermentation products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More

    • The 2025-2030 World Outlook for Biologics Development and Manufacturing Testing

      The 2025-2030 World Outlook for Biologics Development and Manufacturing Testing This study covers the world outlook for biologics development and manufacturing testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More

    • The 2025-2030 World Outlook for Biopharmaceuticals Contract Manufacturing

      The 2025-2030 World Outlook for Biopharmaceuticals Contract Manufacturing This study covers the world outlook for biopharmaceuticals contract manufacturing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More

    • The 2025-2030 World Outlook for Biologic Vasculitis Treatments

      The 2025-2030 World Outlook for Biologic Vasculitis Treatments This study covers the world outlook for biologic vasculitis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Biologics Safety Testing

      The 2025-2030 World Outlook for Biologics Safety Testing This study covers the world outlook for biologics safety testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Biopharma

      The 2025-2030 World Outlook for Biopharma This study covers the world outlook for biopharma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the perce ... Read More

    • The 2023-2028 World Outlook for Biopharmaceuticals

      The 2023-2028 World Outlook for Biopharmaceuticals This study covers the world outlook for biopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2023-2028 World Outlook for Biopharmaceutical Cold Chain Logistics

      The 2023-2028 World Outlook for Biopharmaceutical Cold Chain Logistics This study covers the world outlook for biopharmaceutical cold chain logistics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More

    • The 2023-2028 World Outlook for Biopharmaceutical Excipients

      The 2023-2028 World Outlook for Biopharmaceutical Excipients This study covers the world outlook for biopharmaceutical excipients across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2023-2028 World Outlook for Biologic Therapeutic Drugs

      The 2023-2028 World Outlook for Biologic Therapeutic Drugs This study covers the world outlook for biologic therapeutic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2023-2028 World Outlook for Biologic Vasculitis Treatments

      The 2023-2028 World Outlook for Biologic Vasculitis Treatments This study covers the world outlook for biologic vasculitis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2023-2028 World Outlook for Biopharmaceutical Third Party Logistics

      The 2023-2028 World Outlook for Biopharmaceutical Third Party Logistics This study covers the world outlook for biopharmaceutical third party logistics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2023-2028 World Outlook for Biosimilars and Follow-on Biologics Drugs

      The 2023-2028 World Outlook for Biosimilars and Follow-on Biologics Drugs This study covers the world outlook for biosimilars and follow-on biologics drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More

    • The 2023-2028 World Outlook for Monoclonal Antibody Biopharmaceuticals

      The 2023-2028 World Outlook for Monoclonal Antibody Biopharmaceuticals This study covers the world outlook for monoclonal antibody biopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More

    • The 2023-2028 World Outlook for Single-Use Technology in the Biopharmaceuticals

      The 2023-2028 World Outlook for Single-Use Technology in the Biopharmaceuticals This study covers the world outlook for single-use technology in the biopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More

    • The 2023-2028 World Outlook for Systemic Psoriasis Biologics

      The 2023-2028 World Outlook for Systemic Psoriasis Biologics This study covers the world outlook for systemic psoriasis biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2023-2028 World Outlook for Erythropoietins

      The 2023-2028 World Outlook for Erythropoietins This study covers the world outlook for erythropoietins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More

    • The 2023-2028 World Outlook for Erythropoietin Stimulating Agents

      The 2023-2028 World Outlook for Erythropoietin Stimulating Agents This study covers the world outlook for erythropoietin stimulating agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

    • The 2023-2028 World Outlook for Biopharmaceutical Bioseparation Systems

      The 2023-2028 World Outlook for Biopharmaceutical Bioseparation Systems This study covers the world outlook for biopharmaceutical bioseparation systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2023-2028 World Outlook for Biologics Development and Manufacturing Testing

      The 2023-2028 World Outlook for Biologics Development and Manufacturing Testing This study covers the world outlook for biologics development and manufacturing testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More

    • The 2023-2028 World Outlook for Biopharma Excipients

      The 2023-2028 World Outlook for Biopharma Excipients This study covers the world outlook for biopharma excipients across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2023-2028 World Outlook for Orphan Biologic Drugs

      The 2023-2028 World Outlook for Orphan Biologic Drugs This study covers the world outlook for orphan biologic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2023-2028 World Outlook for Single Use Bioreactors

      The 2023-2028 World Outlook for Single Use Bioreactors This study covers the world outlook for single use bioreactors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2023-2028 World Outlook for Anti-Inflammatory Biologics

      The 2023-2028 World Outlook for Anti-Inflammatory Biologics This study covers the world outlook for anti-inflammatory biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2023-2028 World Outlook for Biopharmaceuticals Contract Manufacturing

      The 2023-2028 World Outlook for Biopharmaceuticals Contract Manufacturing This study covers the world outlook for biopharmaceuticals contract manufacturing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More

1 2 3 4 5

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings